Anti-CD47 antibodies and methods of use
US10570201B2 · kind B2 · utility
3Cited by
12References
39Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 21, 2017 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Nov 9, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.